Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSP3-LSP Vaccine for Malaria in Children
NCT01341704Phase 2Completed
- Sponsor
- Vac4All
- Start
- May 2011
- Primary completion
- Dec 2011
- Modality
- Modified Peptides, Vaccines & Immunotherapeutics, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MSP3-LSP in malaria, sponsored by Vac4All. Started May 2011; status: completed.
02
Drugs
MSP3-LSP
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01341704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341704.